DEI0007415MA - - Google Patents
Info
- Publication number
- DEI0007415MA DEI0007415MA DEI0007415MA DE I0007415M A DEI0007415M A DE I0007415MA DE I0007415M A DEI0007415M A DE I0007415MA
- Authority
- DE
- Germany
- Prior art keywords
- relay
- contact
- contacts
- tube
- control device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000015654 memory Effects 0.000 claims description 124
- 238000012360 testing method Methods 0.000 claims description 53
- 238000012546 transfer Methods 0.000 claims description 6
- 230000001960 triggered effect Effects 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims 1
- 230000000977 initiatory effect Effects 0.000 claims 1
- JJGBFZZXKPWGCW-UHFFFAOYSA-N 2,3-bis[8-[3-[(3-pentyloxiran-2-yl)methyl]oxiran-2-yl]octanoyloxy]propyl 8-[3-[(3-pentyloxiran-2-yl)methyl]oxiran-2-yl]octanoate Chemical compound CCCCCC1OC1CC1C(CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC2C(O2)CC2C(O2)CCCCC)OC(=O)CCCCCCCC2C(O2)CC2C(O2)CCCCC)O1 JJGBFZZXKPWGCW-UHFFFAOYSA-N 0.000 description 84
- 239000003990 capacitor Substances 0.000 description 52
- 238000004804 winding Methods 0.000 description 28
- 238000000034 method Methods 0.000 description 24
- 230000008569 process Effects 0.000 description 23
- 230000004044 response Effects 0.000 description 23
- 238000005070 sampling Methods 0.000 description 22
- 238000010586 diagram Methods 0.000 description 14
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 7
- 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 description 7
- 230000000903 blocking effect Effects 0.000 description 6
- 238000010079 rubber tapping Methods 0.000 description 6
- CDMADVZSLOHIFP-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane;decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 CDMADVZSLOHIFP-UHFFFAOYSA-N 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 101000963506 Danio rerio Methionine-R-sulfoxide reductase B1-A Proteins 0.000 description 4
- 235000005658 Spondias pinnata Nutrition 0.000 description 4
- 244000025012 Spondias pinnata Species 0.000 description 4
- 229910052787 antimony Inorganic materials 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 101150095461 Tfrc gene Proteins 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229910052785 arsenic Inorganic materials 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 2
- 102220615704 Beta-casein_R66D_mutation Human genes 0.000 description 2
- 101100532679 Caenorhabditis elegans scc-1 gene Proteins 0.000 description 2
- 101100428216 Caenorhabditis elegans vab-1 gene Proteins 0.000 description 2
- 101100372582 Caenorhabditis elegans vha-1 gene Proteins 0.000 description 2
- 241000689227 Cora <basidiomycete fungus> Species 0.000 description 2
- 241000295146 Gallionellaceae Species 0.000 description 2
- 102000010292 Peptide Elongation Factor 1 Human genes 0.000 description 2
- 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 2
- 241000953555 Theama Species 0.000 description 2
- 241001377938 Yara Species 0.000 description 2
- 241001080519 Zera Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- FPBHSTHTCPCNBS-QXMYDWGFSA-N methyl N-[(E)-5-[4-hydroxy-5-[(2E,4E,9E,12E)-8-hydroxy-2,5,9-trimethyltetradeca-2,4,9,12-tetraenoyl]-6-oxopyran-2-yl]hex-1-enyl]carbamate Chemical compound COC(=O)N\C=C\CCC(C)C1=CC(O)=C(C(=O)C(\C)=C\C=C(/C)CCC(O)C(\C)=C\C\C=C\C)C(=O)O1 FPBHSTHTCPCNBS-QXMYDWGFSA-N 0.000 description 2
- 208000014380 ornithine aminotransferase deficiency Diseases 0.000 description 2
- FVUJPXXDENYILK-WITUOYQCSA-N (4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(N)=O FVUJPXXDENYILK-WITUOYQCSA-N 0.000 description 1
- BPXVHIRIPLPOPT-UHFFFAOYSA-N 1,3,5-tris(2-hydroxyethyl)-1,3,5-triazinane-2,4,6-trione Chemical compound OCCN1C(=O)N(CCO)C(=O)N(CCO)C1=O BPXVHIRIPLPOPT-UHFFFAOYSA-N 0.000 description 1
- 102220567531 BICD family-like cargo adapter 2_R64A_mutation Human genes 0.000 description 1
- 102220567627 BICD family-like cargo adapter 2_R79A_mutation Human genes 0.000 description 1
- 101100282617 Bovine herpesvirus 1.1 (strain Cooper) gC gene Proteins 0.000 description 1
- 101100511175 Caenorhabditis elegans lim-4 gene Proteins 0.000 description 1
- 101100243558 Caenorhabditis elegans pfd-3 gene Proteins 0.000 description 1
- 101100540263 Caenorhabditis elegans vha-4 gene Proteins 0.000 description 1
- 102220518153 DNA-directed RNA polymerases I and III subunit RPAC1_E13R_mutation Human genes 0.000 description 1
- 241000439706 Hadra Species 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 229910052689 Holmium Inorganic materials 0.000 description 1
- 101000714952 Hololena curta Mu-agatoxin-Hc1c Proteins 0.000 description 1
- 101001057156 Homo sapiens Melanoma-associated antigen C2 Proteins 0.000 description 1
- 102220642659 Inosine-5'-monophosphate dehydrogenase 1_R68D_mutation Human genes 0.000 description 1
- 102100027252 Melanoma-associated antigen C2 Human genes 0.000 description 1
- 102220632447 Mothers against decapentaplegic homolog 3_R74D_mutation Human genes 0.000 description 1
- 102220488128 Olfactory receptor 2A12_R62A_mutation Human genes 0.000 description 1
- 241000283283 Orcinus orca Species 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 102220470542 Proteasome subunit beta type-3_C14S_mutation Human genes 0.000 description 1
- 102220479482 Puromycin-sensitive aminopeptidase-like protein_C21D_mutation Human genes 0.000 description 1
- 102220510525 Retinoic acid receptor alpha_R14D_mutation Human genes 0.000 description 1
- 102220545870 Vacuolar protein sorting-associated protein 41 homolog_R74A_mutation Human genes 0.000 description 1
- SGSXWFDMRKAVLS-UHFFFAOYSA-N [6'-acetyloxy-5-[3-[3-[4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propylcarbamoyl]-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl] acetate Chemical compound C1=C(C=2C(NC(=O)C=2C=2C3=CC=CC=C3N(C)C=2)=O)C2=CC=CC=C2N1CCCNC(=O)C(C=C1C(=O)O2)=CC=C1C12C2=CC=C(OC(C)=O)C=C2OC2=CC(OC(=O)C)=CC=C12 SGSXWFDMRKAVLS-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 208000031477 focal task-specific dystonia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 101150081094 ispG gene Proteins 0.000 description 1
- 229910052745 lead Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 102200127601 rs281864947 Human genes 0.000 description 1
- 102220008913 rs33960103 Human genes 0.000 description 1
- 102200082934 rs35474880 Human genes 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 108700043117 vasectrin I Proteins 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 101150052261 vha-2 gene Proteins 0.000 description 1
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1437494C3 (de) | Schaltungsanordnung zur Suche und Herstellung von Verbindungswegen in Fernmelde vermlttlungs-, insbesondere Fernsprechvermittlungsanlagen | |
| DE896667C (de) | Fernvermittlungssystem | |
| DE959287C (de) | Schaltungsanordnung fuer zentrale Steuereinrichtungen in Fernmelde-, insbesondere Fernsprechanlagen | |
| DE910911C (de) | Stromkreisanordnung zur selbsttaetigen Verbindung eines ersten Satzes gleichartiger elektrischer Stromkreise mit einem zweiten Satz gleichartiger elektrischer Stromkreise | |
| DE868931C (de) | Schaltungsanordnung zur Herstellung von Verbindungen in Fernmeldeanlagen | |
| DE1955296A1 (de) | Fernsprechvermittlungsanlage mit Anruf-Wartet-Sonderbedienung | |
| DE934107C (de) | Schaltungsanordnung fuer Vermittlungssystem, insbesondere Fernsprechsystem | |
| DEI0007415MA (en(2012)) | ||
| DE674741C (de) | Schaltungsanordnung fuer Fernsprechanlagen mit Waehlerbetrieb und ueber Vierdrahtleitungen miteinander verbundenen Zweidrahtsystemen | |
| DE1083344B (de) | Schaltungsanordnung fuer Fernsprechanlagen, in denen die Verbindungsherstellung durch Magnettrommelspeicher gesteuert wird | |
| DE853302C (de) | Schaltungsanordnung zur Herstellung von Verbindungen in Fernmeldeanlagen | |
| DE932804C (de) | Vermittlungssystem fuer automatische Fernsprechanlagen | |
| DE1243736B (de) | Schaltungsanordnung zum selbsttaetigen Verbinden von Teilnehmerleitungen mit einer elektronischen Vermittlungsstelle in Fernmelde-, insbesondere Fernsprechanlagen mit Gruppenstellen | |
| DE923672C (de) | Schaltungsanordnung fuer ein selbsttaetiges Fernsprechsystem | |
| DE940359C (de) | Verbindungsschema fuer ein automatisches Signalsystem | |
| DE921330C (de) | Pruefschaltung zum Einstellen eines Endwaehlers | |
| DE557890C (de) | Schaltungsanordnung fuer Fernsprechanlagen mit Waehlerbetrieb | |
| DE655922C (de) | Schaltungsanordnung fuer Fernsprechanlagen mit mehreren Vermittlungsstellen und Anschlussstellen verschiedener Verkehrsberechtigung | |
| DE663155C (de) | Schaltung fuer Untervermittlungsstellen | |
| DE681436C (de) | Schaltungsanordnung fuer Nebenstellenanlagen mit Waehlerbetrieb | |
| DE641060C (de) | Schaltungsanordnung fuer Fernsprechanlagen | |
| DE381922C (de) | Schaltungsanordnung fuer Fernsprechanlagen mit Waehlerbetrieb | |
| AT91568B (de) | Mit selbsttätigen Schaltwerken betriebenes Fernsprechvermittlungssystem. | |
| DE659640C (de) | Schaltungsanordnung in Fernmelde-, insbesondere Fernsprechanlagen | |
| DE1237183B (de) | Schaltungsanordnung fuer Fernmeldeanlagen, insbesondere Fernsprechvermittlungsanlagen, mit Haupt- und Untervermittlungsstellen |